IVIG for Infection Prevention After CAR-T-Cell Therapy
Condition:   Lymphoma Interventions:   Biological: Immune Globulin Infusion (Human), 10% Solution;   Biological: Anti-CD19-targeting CAR-T Cells;   Other: Saline;   Procedure: Biospecimen Collection;   Other: Survey Administration;   Other: Electronic Health Record Review Sponsors:   Fred Hutchinson Cancer Center;   Takeda;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2023 Category: Research Source Type: clinical trials

Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
Conditions:   Lung Transplant;   Hepatitis B Intervention:   Drug: Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide Sponsor:   University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials